Yulong Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yulong Zhang has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Xinghua Pan
Precision Regenerative Medicine Research Centre, Medical Science Division, and State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, 999078, Macao Special Administrative Region of China
2 shared publications - Changtai Xiao
Southern Medical University, and Guangdong Provincial Key Laboratory of Single Cell Technology and Application Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences Guangzhou 510515
1 shared publication - Chuqing Huang
Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
1 shared publication - Guanchuan Lin
Southern Medical University, and Guangdong Provincial Key Laboratory of Single Cell Technology and Application Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences Guangzhou 510515
1 shared publication - Hui Liu
The Affiliated Qingyuan Hospital of Guangzhou Medical University, Qingyuan People's Hospital, the Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510080, China; The State Key Laboratory of Respiratory Disease and National Clinical Research Center for Respiratory Disease, Guangzhou Medical University, Guangzhou, 510182, China; Center for Liver Diseases of Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, 510440, China
1 shared publication - Jiahong Wang
Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University
1 shared publication
Latest Publications
- Open Access
- 2 December 2025
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
Profiling Cell-state Fingerprints Based on Deep Learning Model with Meta-programs of Pan-cancer
Cell states within cancer have garnered significant attention, yet the mechanisms through which malignant cells assert dominance in pan-cancer commonalities remain elusive. In this study, we employed label-free multiplexed single-cell RNA sequencing (scRNA-seq) to analyze cell states in 159,372 cells across 245 cell lines spanning 14 tissue types, integrating both public and proprietary datasets. We identified 21 meta-programs (MPs) representing shared characteristics across pan-cancer landscapes, encompassing 16 biological processes. Subsequently, we developed a deep learning model StateNet to generate cell-state fingerprints for delineating the individuality of each cell line based on these MPs. Leveraging StateNet, we pinpointed ACAT2 as a potential mediator bridging hypoxia and the lipid metabolism pathway, and we also showcased that epithelial–mesenchymal transition programs are vital for classifying cell lines through perturbation experiments. StateNet not only elucidates the overarching manifold structure of scRNA-seq data but also furnishes cell-state fingerprints of cell clusters, unveiling prognosis-related programs and distinguishing between patients with varying survival outcomes. Utilizing these prognosis-related programs on 3210 cancer samples, we constructed Cox models and identified risk-associated programs and genes responsible for different cancer types. StateNet thus emerges as a novel and efficient tool for cancer profiling, unraveling the shared commonalities and distinct individualities of pan-cancer cells across expansive datasets.
- 2 December 2025
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
Open AccessProfiling Cell-state Fingerprints Based on Deep Learning Model with Meta-programs of Pan-cancer
Cell states within cancer have garnered significant attention, yet the mechanisms through which malignant cells assert dominance in pan-cancer commonalities remain elusive. In this study, we employed label-free multiplexed single-cell RNA sequencing (scRNA-seq) to analyze cell states in 159,372 cells across 245 cell lines spanning 14 tissue types, integrating both public and proprietary datasets. We identified 21 meta-programs (MPs) representing shared characteristics across pan-cancer landscapes, encompassing 16 biological processes. Subsequently, we developed a deep learning model StateNet to generate cell-state fingerprints for delineating the individuality of each cell line based on these MPs. Leveraging StateNet, we pinpointed ACAT2 as a potential mediator bridging hypoxia and the lipid metabolism pathway, and we also showcased that epithelial–mesenchymal transition programs are vital for classifying cell lines through perturbation experiments. StateNet not only elucidates the overarching manifold structure of scRNA-seq data but also furnishes cell-state fingerprints of cell clusters, unveiling prognosis-related programs and distinguishing between patients with varying survival outcomes. Utilizing these prognosis-related programs on 3210 cancer samples, we constructed Cox models and identified risk-associated programs and genes responsible for different cancer types. StateNet thus emerges as a novel and efficient tool for cancer profiling, unraveling the shared commonalities and distinct individualities of pan-cancer cells across expansive datasets.
- Open Access
- 1 January 2024
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 16 (1) , 55-70
Sputum Transcriptomics Reveals FCN1+ Macrophage Activation in Mild Eosinophilic Asthma Compared to Non-Asthmatic Eosinophilic Bronchitis
Zhan W, et al. Allergy Asthma Immunol Res. 2024 Jan;16(1):55-70. https://doi.org/10.4168/aair.2024.16.1.55
- 1 January 2024
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 16 (1) , 55-70
Open AccessSputum Transcriptomics Reveals FCN1+ Macrophage Activation in Mild Eosinophilic Asthma Compared to Non-Asthmatic Eosinophilic Bronchitis
Zhan W, et al. Allergy Asthma Immunol Res. 2024 Jan;16(1):55-70. https://doi.org/10.4168/aair.2024.16.1.55